Reported Reactions

Devices › Calibrator, multi-analyte mixture

Device brand name · For use in the calibration of the clinical chemistry bilirubin assay

Clinical Chemistry Bilirubin Calibrator: medical device reports filed with FDA

257 reports name it, 2007–2009. Manufacturer given most often on reports: Abbott Manufacturing. Product code JIX.

257
device reports naming the brand
0% of all MAUDE reports · about 14 a year
0
reports, 12 months to August 2026
0 in the 12 months before
99.6%
classified as malfunction
98.5% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

257 medical device reports received by FDA name the brand "Clinical Chemistry Bilirubin Calibrator" (for use in the calibration of the clinical chemistry bilirubin assay); the manufacturer given most often on reports is Abbott Manufacturing; received from September 2007 to August 2009. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (99.6%) and injury (0.4%); across all calibrator, multi-analyte mixture reports (product code JIX) death is recorded in 0% and malfunction in 98.5%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are low test results (58.8%), high test results (36.6%) and high readings (28.8%). The patient problems coded most often are hospitalization required, therapy/non-surgical treatment, additional and transfusion of blood products. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Clinical Chemistry Bilirubin Calibrator was received in the five years to August 2026; the latest was received in August 2009.

By year received

0561122007: 11220072008: 11020082009: 352009

Event type and report source

Event type, as classified on the report

Death0%0
Injury0.4%1
Malfunction99.6%256
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%257
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 582 reports carrying product code JIX. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Low test results15158.8%32.5%
High test results9436.6%40.4%
High readingsreadings were too high7428.8%13.9%
Incorrect or inadequate test results72.7%3.1%
Failure to recalibrate20.8%0.3%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Hospitalization required20.8%
Therapy/non-surgical treatment, additional10.4%
Transfusion of blood products10.4%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureClinical Chemistry Bilirubin CalibratorProduct code JIXAll MAUDE reports
Reports25758226,136,888
Share of that pool—44.2%0%
Classified as death, per 1,000 reports009
Classified as injury0.4%1.4%36.2%
Classified as malfunction99.6%98.5%62.3%
Filed by the manufacturer100%98.5%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code JIX

BrandReportsLatest 12 monthsClassified as death
Dimension Vista R Clinical Chemistry System20800%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Clinical Chemistry Bilirubin Calibrator reports

How many FDA reports name Clinical Chemistry Bilirubin Calibrator?

257 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (99.6%) and injury (0.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

low test results (58.8%), high test results (36.6%), high readings (28.8%), incorrect or inadequate test results (2.7%) and failure to recalibrate (0.8%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Clinical Chemistry Bilirubin Calibrator was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.